Cargando…
Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways
T-006, a new derivative of tetramethylpyrazine, has been recently found to protect against 6-hydroxydopamine (6-OHDA)-induced neuronal damage and clear α-synuclein (α-syn) by enhancing proteasome activity in an α-syn transgenic Parkinson’s disease (PD) model. The effect of T-006 on the 1-methyl-4-ph...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425444/ https://www.ncbi.nlm.nih.gov/pubmed/32710729 http://dx.doi.org/10.18632/aging.103551 |
_version_ | 1783570494607327232 |
---|---|
author | Chen, Haiyun Cao, Jie Zha, Ling Wang, Peile Liu, Zheng Guo, Baojian Zhang, Gaoxiao Sun, Yewei Zhang, Zaijun Wang, Yuqiang |
author_facet | Chen, Haiyun Cao, Jie Zha, Ling Wang, Peile Liu, Zheng Guo, Baojian Zhang, Gaoxiao Sun, Yewei Zhang, Zaijun Wang, Yuqiang |
author_sort | Chen, Haiyun |
collection | PubMed |
description | T-006, a new derivative of tetramethylpyrazine, has been recently found to protect against 6-hydroxydopamine (6-OHDA)-induced neuronal damage and clear α-synuclein (α-syn) by enhancing proteasome activity in an α-syn transgenic Parkinson’s disease (PD) model. The effect of T-006 on the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD model, however, has not been tested and T-006’s neuroprotective mechanisms have not been fully elucidated. In this study, we further investigated the neuroprotective and neurogenic effects of T-006 and explored its underlying mechanism of action in both cellular and animal PD models. T-006 was able to improve locomotor behavior, increase survival of nigra dopaminergic neurons and boost striatal dopamine levels in both MPTP- and 6-OHDA-induced animals. T-006 treatment restored the altered expressions of myocyte enhancer factor 2D (MEF2D), peroxisome proliferator-activated receptor γ (PPARγ) co-activator 1α (PGC1α) and NF-E2-related factor 1/2 (Nrf1/2) via modulation of Akt/GSK3β signaling. T-006 stimulated MEF2, PGC1α and Nrf2 transcriptional activities, inducing Nrf2 nuclear localization. Interestingly, T-006 promoted endogenous adult neurogenesis toward a dopaminergic phenotype by activating brain-derived neurotrophic factor (BDNF) and cAMP responsive element-binding protein (CREB) in 6-OHDA rats. Our work demonstrated that T-006 is a potent neuroprotective and neuroregenerative agent that may have therapeutic potential in the treatment of PD. |
format | Online Article Text |
id | pubmed-7425444 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-74254442020-08-25 Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways Chen, Haiyun Cao, Jie Zha, Ling Wang, Peile Liu, Zheng Guo, Baojian Zhang, Gaoxiao Sun, Yewei Zhang, Zaijun Wang, Yuqiang Aging (Albany NY) Research Paper T-006, a new derivative of tetramethylpyrazine, has been recently found to protect against 6-hydroxydopamine (6-OHDA)-induced neuronal damage and clear α-synuclein (α-syn) by enhancing proteasome activity in an α-syn transgenic Parkinson’s disease (PD) model. The effect of T-006 on the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced PD model, however, has not been tested and T-006’s neuroprotective mechanisms have not been fully elucidated. In this study, we further investigated the neuroprotective and neurogenic effects of T-006 and explored its underlying mechanism of action in both cellular and animal PD models. T-006 was able to improve locomotor behavior, increase survival of nigra dopaminergic neurons and boost striatal dopamine levels in both MPTP- and 6-OHDA-induced animals. T-006 treatment restored the altered expressions of myocyte enhancer factor 2D (MEF2D), peroxisome proliferator-activated receptor γ (PPARγ) co-activator 1α (PGC1α) and NF-E2-related factor 1/2 (Nrf1/2) via modulation of Akt/GSK3β signaling. T-006 stimulated MEF2, PGC1α and Nrf2 transcriptional activities, inducing Nrf2 nuclear localization. Interestingly, T-006 promoted endogenous adult neurogenesis toward a dopaminergic phenotype by activating brain-derived neurotrophic factor (BDNF) and cAMP responsive element-binding protein (CREB) in 6-OHDA rats. Our work demonstrated that T-006 is a potent neuroprotective and neuroregenerative agent that may have therapeutic potential in the treatment of PD. Impact Journals 2020-07-24 /pmc/articles/PMC7425444/ /pubmed/32710729 http://dx.doi.org/10.18632/aging.103551 Text en Copyright © 2020 Chen et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Chen, Haiyun Cao, Jie Zha, Ling Wang, Peile Liu, Zheng Guo, Baojian Zhang, Gaoxiao Sun, Yewei Zhang, Zaijun Wang, Yuqiang Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways |
title | Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways |
title_full | Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways |
title_fullStr | Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways |
title_full_unstemmed | Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways |
title_short | Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson’s disease models through activating the MEF2-PGC1α and BDNF/CREB pathways |
title_sort | neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative t-006 in parkinson’s disease models through activating the mef2-pgc1α and bdnf/creb pathways |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425444/ https://www.ncbi.nlm.nih.gov/pubmed/32710729 http://dx.doi.org/10.18632/aging.103551 |
work_keys_str_mv | AT chenhaiyun neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT caojie neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT zhaling neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT wangpeile neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT liuzheng neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT guobaojian neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT zhanggaoxiao neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT sunyewei neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT zhangzaijun neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways AT wangyuqiang neuroprotectiveandneurogeniceffectsofnoveltetramethylpyrazinederivativet006inparkinsonsdiseasemodelsthroughactivatingthemef2pgc1aandbdnfcrebpathways |